—

Axsome Therapeutics Inc (AXSM) — the peer cohort

As of 2026-11-10 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Axsome Therapeutics Inc ranks 7 of 7 in its cohort on the Closelooknet composite (36/100) — the cohort is led by Halozyme Therapeutics Inc at 70/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
AXSM Axsome Therapeutics Inc 36 12 23 19 warn 45.8%
HALO Halozyme Therapeutics Inc 70 76 94 36 info 23.1%
ARGX.BR Argen-X 65 85 75 28 ok 6.6%
ONC BeOne Medicines AG 65 91 64 29 ok 0.2%
REGN Regeneron Pharmaceuticals Inc 64 84 72 45 bull 7.2%
UCB.BR UCB SA 64 77 71 41 info 2.2%
ARGX argenx NV ADR 63 79 74 27 ok 9.4%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-10

Quick answers

Who are Axsome Therapeutics Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), UCB SA (UCB.BR), argenx NV ADR (ARGX), as of 2026-11-10.

How does AXSM score against its peers?

Axsome Therapeutics Inc's composite reads 36/100, ranking 7 of 7 in its cohort as of 2026-11-10; the cohort's highest composite is Halozyme Therapeutics Inc at 70/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.